Circle K is moving into Florida cannabis sales, giving Trulieve Cannabis a new mainstream distribution channel in the state where it already operates 169 dispensaries and where regulatory access remains the biggest driver of growth for U.S. marijuana operators.
Trulieve Gains Florida Cannabis Access via Circle K

The move matters because Florida is one of the largest cannabis markets in the country and remains the key profit pool for Trulieve, the state’s dominant medical marijuana operator. Any expansion beyond stand-alone dispensaries into convenience-store traffic could widen customer reach, lower acquisition costs and support higher sales density, even as legal cannabis remains tightly controlled and still faces federal restrictions.
Trulieve shares, which trade on the Nasdaq under TRLV, closed at $10.92 on Oct. 22 after a volatile stretch that included a drop from $13 on June 8. The stock is above its 50-day moving average of $11.10 and well above its 200-day average of $8.76, while RSI at 53 suggests the recent rebound is not yet stretched. That leaves investors focused less on daily price action than on whether Florida distribution can translate into sustained revenue growth and margin improvement.
The broader cannabis trade has been crushed and revived in waves as investors alternate between legalization optimism and policy frustration. That backdrop is reflected in smaller names such as BUDZ, which trades around a penny and underscores how difficult the sector remains for capital-starved operators outside the biggest state markets.
For Trulieve, the immediate question is whether the Circle K rollout becomes a meaningful sales lift or just a marketing novelty. Investors will be watching for store count, product assortment and consumer response in Florida, where any real expansion in access could strengthen the company’s lead as rivals wait for broader U.S. reform.
| Entity | Gains | Losses |
|---|---|---|
| Trulieve (TRLV) | ▲Wider Florida reach | ▼Higher execution risk |
| Circle K | ▲Store traffic uplift | ▼Regulatory complexity |
| Florida consumers | ▲Easier access | ▼Fewer pricing bargains |
| Smaller cannabis rivals | ▲Little immediate gain | ▼Shelf-space pressure |


